En Es
Categorías

DIAGNOSTICA STAGO

Offers a complete system of hemostasis instrumentation and optimized reagent kits for research, as well as for routine analysis
Productos NoticiasResumen
Close

Noticias of DIAGNOSTICA STAGO

Diagnostica Stago Introduces New MyOptiLab Workflow Analysis Service

30 Jun 2021
Diagnostica Stago Introduces New MyOptiLab Workflow Analysis Service
Diagnostica Stago (Asnières-sur-Seine, France) has introduced its new MyOptiLab workflow analysis service as part of a broader strategy aimed at working more closely with laboratories. It is an elaborate process designed to optimize organizational excellence.
Más info

Stago Connect.One Network Allows Remote Monitoring of Analyzers

09 Aug 2018
Stago Connect.One Network Allows Remote Monitoring of Analyzers
Diagnostica Stago, an in-vitro diagnostics company focusing on thrombosis and hemostasis, has launched the secure Connect.One network architecture, which allows laboratories to benefit from remote monitoring of their automated analyzers.
Más info

Stago Group Acquires HemoSonics

30 May 2017
Stago Group Acquires HemoSonics
The Stago Group, which develops and markets automated systems for blood analysis in coagulation, has completed the acquisition of HemoSonics LLC, a developer of point-of-care (POC) testing solutions.
Más info
Close

Sobre DIAGNOSTICA STAGO

Número de empleados: 1000+
Año de establecimiento 1945
Offers a complete system of hemostasis instrumentation and optimized reagent kits for research, as well as for routine analysis
Facebook Twitter Google+ Linked in
D-Dimer Immuno-Turbidimetric Assay

D-Dimer Immuno-Turbidimetric Assay

Modelo: STA-Liatest D-Di Plus
Solicite información

Descripción:

STA-Liatest D-Di Plus was developed as an evolution of the STA-Liatest D-Di, one of the most published D-Dimer assays, also FDA approved for aid in the diagnosis of Venous Thrombo Embolism (VTE). In STA-Liatest D-Di Plus, the addition of a blocking agent improves the analytical and diagnostic performances of the assay by minimizing interferences to heterophilic antibodies, including rheumatoid factors (RF) and Human Anti-Mouse Antibodies (HAMA).
Más info

Descripción completa

Descripción

STA-Liatest D-Di Plus was developed as an evolution of the STA-Liatest D-Di, one of the most published D-Dimer assays, also FDA approved for aid in the diagnosis of Venous Thrombo Embolism (VTE). In STA-Liatest D-Di Plus, the addition of a blocking agent improves the analytical and diagnostic performances of the assay by minimizing interferences to heterophilic antibodies, including rheumatoid factors (RF) and Human Anti-Mouse Antibodies (HAMA). By minimizing the interferences from heterophilic antibodies, STA-Liatest D-Di Plus has been designed to show improved specificity for even more efficacy. Solicite información

Enviar un mensaje al proveedor

* Información requerida
* Email:
Para
DIAGNOSTICA STAGO ()
* Mensaje

Derecho de autor © 2000-2022 TradeMed.com. Todos los derechos reservados. | Términos y condiciones